These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 25595570

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
    Jiang Y, Wang F, Xu H, Liu H, Meng Q, Liu W.
    Int J Pharm; 2014 Nov 20; 475(1-2):475-84. PubMed ID: 25219858
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP, Vavia PR.
    Pharm Dev Technol; 2014 Jun 20; 19(4):385-94. PubMed ID: 23590187
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
    Otsuka M, Uenodan H, Matsuda Y, Mogi T, Ohshima H, Makino K.
    Biomed Mater Eng; 2002 Jun 20; 12(2):157-67. PubMed ID: 12122239
    [Abstract] [Full Text] [Related]

  • 12. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S, Faraj J, DeLuca P.
    Eur J Pharm Biopharm; 2013 Nov 20; 85(3 Pt A):631-9. PubMed ID: 23892159
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
    Correa CB, Camargos GV, Chatterjee M, Mesquita MF, Del Bel Cury AA, Naert I, Duyck J, Vandamme K.
    Osteoporos Int; 2017 Apr 20; 28(4):1287-1293. PubMed ID: 27921147
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.
    Fisher JE, Scott K, Wei N, Zhao JZ, Cusick T, Tijerina M, Karanam B, Duong L, Glantschnig H.
    Bone; 2012 Jun 20; 50(6):1332-42. PubMed ID: 22445539
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.